iHCK-37

N/A

Report date: 2023/07/10 09:40:15
NME

Base Information

Drug NameiHCK-37
Drug Alias NameiHCK-37
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase HCK inhibitors
TargetsTyrosine-protein kinase HCK
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Campinas, Brazil
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Campinas, Brazil
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A